Nisa Investment Advisors’s IGM Biosciences IGMS Stock Holding History

Nisa Investment Advisors’s Portfolio IGMS Stock Details IGMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-563	Closed	-$631	–	3031
2025 Q2	$631	Sell	563 -165	-23%	-$202	﹤0.01%	2834
2025 Q1	$837	Sell	728 -3,226	-82%	-$6K	﹤0.01%	2683
2024 Q4	$24.2K	Sell	3,954 -6	-0.2%	-$71	﹤0.01%	1882
2024 Q3	$65.5K	Buy	3,960 +54	+1%	+$592	﹤0.01%	1566
2024 Q2	$26.8K	Sell	3,906 -6	-0.2%	-$51	﹤0.01%	1840
2024 Q1	$37.8K	Buy	3,912 +12	+0.3%	+$139	﹤0.01%	1721
2023 Q4	$32.4K	Buy	3,900 +3,847	+7,258%	+$22.3K	﹤0.01%	1734
2023 Q3	$443	Buy	+53	New	+$450	﹤0.01%	2549
2023 Q2	–	Sell	-24	Closed	–	–	2833
2023 Q1	$0	Hold	24	–	–	﹤0.01%	2598
2022 Q4	$0	Buy	+24	New	+$480	﹤0.01%	2634
2021 Q3	–	Sell	-600	Closed	-$50	–	2313
2021 Q2	$50	Buy	+600	New	+$44.5K	﹤0.01%	1944

Other funds holding IGMS

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Nisa Investment Advisors's IGMS Position: Q3 2025 in Review

Nisa Investment Advisors sold out of IGM Biosciences (IGMS) in Q3 2025, closing a stake of 563 shares — an estimated $631 sold.

Nisa Investment Advisors first reported a position in IGMS in Q2 2021 and held it in 11 quarters. The position peaked at $65.5K in Q3 2024. 1 fund tracked by Wall St. Rank holds IGMS as of Q3 2025.

Nisa Investment Advisors reported no remaining IGM Biosciences position as of Q3 2025 after selling out during the quarter.
Nisa Investment Advisors sold 563 IGM Biosciences shares in Q3 2025, an estimated $631.
Nisa Investment Advisors first reported a position in IGM Biosciences in Q2 2021 and held it in 11 quarters.
Nisa Investment Advisors's IGM Biosciences position peaked at $65.5K in Q3 2024.
1 fund tracked by Wall St. Rank held IGM Biosciences as of Q3 2025.

Based on Nisa Investment Advisors's 13F filing for Q3 2025, filed 23 Oct 2025.